PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism

被引:336
作者
Medina-Gomez, Gema
Gray, Sarah L.
Yetukuri, Laxman
Shimomura, Kenju
Virtue, Sam
Campbell, Mark
Curtis, R. Keira
Jimenez-Linan, Mercedes
Blount, Margaret
Yeo, Giles S. H.
Lopez, Miguel
Seppanen-Laakso, Tuulikki
Ashcroft, Frances M.
Oresic, Matej
Vidal-Puig, Antonio [1 ]
机构
[1] Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem Histopathol, Cambridge CB2 1TN, England
[2] Tech Res Ctr Finland, VTT, Espoo, Finland
[3] Univ Oxford, Physiol Lab, Oxford OX1 2JD, England
来源
PLOS GENETICS | 2007年 / 3卷 / 04期
基金
英国医学研究理事会;
关键词
D O I
10.1371/journal.pgen.0030064
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Peroxisome proliferator activated receptor gamma 2 (PPARg2) is the nutritionally regulated isoform of PPARg. Ablation of PPARg2 in the ob/ob background, PPARg2(-/-) Lep(ob)/Lep(ob) (POKO mouse), resulted in decreased fat mass, severe insulin resistance, beta-cell failure, and dyslipidaemia. Our results indicate that the PPARg2 isoform plays an important role, mediating adipose tissue expansion in response to positive energy balance. Lipidomic analyses suggest that PPARg2 plays an important antilipotoxic role when induced ectopically in liver and muscle by facilitating deposition of fat as relatively harmless triacylglycerol species and thus preventing accumulation of reactive lipid species. Our data also indicate that PPARg2 may be required for the beta-cell hypertrophic adaptive response to insulin resistance. In summary, the PPARg2 isoform prevents lipotoxicity by ( a) promoting adipose tissue expansion, (b) increasing the lipid-buffering capacity of peripheral organs, and ( c) facilitating the adaptive proliferative response of beta-cells to insulin resistance.
引用
收藏
页码:0634 / 0647
页数:14
相关论文
共 59 条
  • [1] PPARγ is required for placental, cardiac, and adipose tissue development
    Barak, Y
    Nelson, MC
    Ong, ES
    Jones, YZ
    Ruiz-Lozano, P
    Chien, KR
    Koder, A
    Evans, RM
    [J]. MOLECULAR CELL, 1999, 4 (04) : 585 - 595
  • [2] Proposed mechanisms for the induction of insulin resistance by oxidative stress
    Bloch-Damti, A
    Bashan, N
    [J]. ANTIOXIDANTS & REDOX SIGNALING, 2005, 7 (11-12) : 1553 - 1567
  • [3] Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat
    Braissant, O
    Foufelle, F
    Scotto, C
    Dauca, M
    Wahli, W
    [J]. ENDOCRINOLOGY, 1996, 137 (01) : 354 - 366
  • [4] Inflammation: the link between insulin resistance, obesity and diabetes
    Dandona, P
    Aljada, A
    Bandyopadhyay, A
    [J]. TRENDS IN IMMUNOLOGY, 2004, 25 (01) : 4 - 7
  • [5] Expression of peroxisome proliferator-activated receptor γ (PPARγ) in normal human pancreatic islet cells
    Dubois, M
    Pattou, F
    Kerr-Conte, J
    Gmyr, V
    Vandewalle, B
    Desreumaux, P
    Auwerx, J
    Schoonjans, K
    Lefebvre, J
    [J]. DIABETOLOGIA, 2000, 43 (09) : 1165 - 1169
  • [6] Elia M, 1992, World Rev Nutr Diet, V70, P68
  • [7] Rat PPARs: Quantitative analysis in adult rat tissues and regulation in fasting and refeeding
    Escher, P
    Braissant, O
    Basu-Modak, S
    Michalik, L
    Wahli, W
    Desvergne, B
    [J]. ENDOCRINOLOGY, 2001, 142 (10) : 4195 - 4202
  • [8] Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of type 2 diabetes
    Evans, JL
    Goldfine, ID
    Maddux, BA
    Grodsky, GM
    [J]. ENDOCRINE REVIEWS, 2002, 23 (05) : 599 - 622
  • [9] Reactive species and early manifestation of insulin resistance in type 2 diabetes
    Fridlyand, LE
    Philipson, LH
    [J]. DIABETES OBESITY & METABOLISM, 2006, 8 (02) : 136 - 145
  • [10] Liver peroxisome proliferator-activated receptor γ contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass
    Gavrilova, O
    Haluzik, M
    Matsusue, K
    Cutson, JJ
    Johnson, L
    Dietz, KR
    Nicol, CJ
    Vinson, C
    Gonzalez, FJ
    Reitman, ML
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (36) : 34268 - 34276